Hadeel S. Kheraldine

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Correction: Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Correction: Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Journal: Frontiers in pharmacology
Published: April 22, 2026

Safety evaluation of a ketamine-dodecyl maltoside combination using angiogenesis and embryonic development models.

Safety evaluation of a ketamine-dodecyl maltoside combination using angiogenesis and embryonic development models.

Journal: Scientific reports
Published: February 02, 2026

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Journal: Scientific reports
Published: January 27, 2026

Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Developmental and angiogenic safety profiles of novel pyridine-based chalcone.

Journal: Frontiers in pharmacology
Published: January 03, 2026

Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer.

Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 13, 2025

Graphitic carbon nitride for biomedical applications: challenges and future opportunities in dentistry.

Graphitic carbon nitride for biomedical applications: challenges and future opportunities in dentistry.

Journal: Discover nano
Published: October 28, 2025

Ketamine and dodecyl maltoside synergy as a potential topical therapeutic approach for melanoma.

Ketamine and dodecyl maltoside synergy as a potential topical therapeutic approach for melanoma.

Journal: Scientific reports
Published: July 11, 2025

Inflammation-associated drug resistance and tumor growth in TNBC.

Inflammation-associated drug resistance and tumor growth in TNBC.

Journal: Frontiers in immunology
Published: May 06, 2025

Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer.

Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 12, 2025

Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model.

Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model.

Journal: Biomolecules & biomedicine
Published: September 28, 2023

Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.

Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 16, 2023

Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.

Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.

Journal: Cancer cell international
Published: January 01, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026